Stay updated on Pembrolizumab in Neoplasms Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T14:02:23.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T06:26:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-24T01:33:22.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the removal of detailed information about a Phase II clinical trial for pembrolizumab and its associated criteria, while adding new terminology related to lymphoma types and a revision version update.
    Difference
    43%
    Check dated 2025-04-16T20:40:10.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-01-03.
    Difference
    0.5%
    Check dated 2025-04-09T14:53:27.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 3, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-02T00:18:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.